Literature DB >> 6453036

Covert suppressor T cells in Crohn's disease.

C O Elson, A S Graeff, S P James, W Strober.   

Abstract

To determine whether patients with Crohn's disease have a defect in immune regulation, suppressor T-cell activity was assessed in 16 patients with mild or inactive Crohn's disease and was compared with that of an equal number of randomly selected normal controls. Pokeweed mitogen-stimulated cultures of peripheral blood lymphocytes from patients synthesized as much IgM as those from normal controls. In addition, cocultures of patient and normal peripheral blood lymphocytes did not result in either suppression or enhancement of immunoglobulin M synthesis. In contrast to these results with cultures of peripheral blood lymphocytes, cultures containing optimal ratios of purified B cells and T cells from patients synthesized significantly less immunoglobulin M (p less than 0.005) than those from normals; in fact, the latter cultures from 6 patients synthesized no detectable immunoglobulin M. Detailed studies of cells from these patients indicated that a suppressor T cell was revealed in vitro during the cell-purification procedure. Finally, in those patients in whom it could be measured, radiation-sensitive suppressor T-cell activity was found to be normal. We conclude that there is no deficiency of suppressor T cells regulating antibody synthesis in patients with Crohn's disease; on the contrary, at least one-half of these patients have suppressor T cells that markedly inhibit the synthesis of immunoglobulin M, but which are revealed only after purification of the T cells.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6453036

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  27 in total

1.  CD5+ B cells are decreased in peripheral blood of patients with Crohn's disease.

Authors:  G A Neil; R W Summers; B A Cheyne; C Capenter; W L Huang; G S Kansas; T J Waldschmidt
Journal:  Dig Dis Sci       Date:  1992-09       Impact factor: 3.199

2.  Antigen induced suppression in peripheral blood and lamina propria mononuclear cells in inflammatory bowel disease.

Authors:  H R Dalton; P Hoang; D P Jewell
Journal:  Gut       Date:  1992-03       Impact factor: 23.059

3.  Soluble interleukin-2 receptor in Crohn's disease: relation of serum concentrations to disease activity.

Authors:  J E Crabtree; L D Juby; R V Heatley; A J Lobo; D W Bullimore; A T Axon
Journal:  Gut       Date:  1990-09       Impact factor: 23.059

Review 4.  The immunology of inflammatory bowel disease.

Authors:  J R Lowes; D P Jewell
Journal:  Springer Semin Immunopathol       Date:  1990

5.  The CD8+ Leu-7+ subset of T cells in Crohn's disease: distinction between cytotoxic and covert suppressor functions.

Authors:  R L Deem; S R Targan; A Niederlehner; F Shanahan
Journal:  Clin Exp Immunol       Date:  1990-06       Impact factor: 4.330

Review 6.  Selective T cell immunoregulatory function and contrasuppression in the mucosal immune system.

Authors:  L Braun-Elwert; S P James
Journal:  Immunol Res       Date:  1991       Impact factor: 2.829

7.  A limiting-dilution analysis of activated circulating B cells in Crohn's disease.

Authors:  M Boirivant; F Quintieri; O Pugliese; G Famularo; S Fais; F Pallone
Journal:  J Clin Immunol       Date:  1990-03       Impact factor: 8.317

8.  Elevated numbers of peripheral T cells in inflammatory bowel diseases displaying T9 antigen and Fc alpha receptors.

Authors:  A Raedler; S Fraenkel; G Klose; H G Thiele
Journal:  Clin Exp Immunol       Date:  1985-06       Impact factor: 4.330

9.  Loss of suppressor T-cells in active inflammatory bowel disease.

Authors:  N J Godin; D B Sachar; R Winchester; C Simon; H D Janowitz
Journal:  Gut       Date:  1984-07       Impact factor: 23.059

10.  In vitro immunoglobulin secretion by normal human gastrointestinal mucosal tissues, and alterations in patients with inflammatory bowel disease.

Authors:  V A Danis; A D Harries; R V Heatley
Journal:  Clin Exp Immunol       Date:  1984-04       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.